159 related articles for article (PubMed ID: 8887453)
1. Eptastigmine-phosphotriesterase combination in DFP intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicol Appl Pharmacol; 1996 Oct; 140(2):364-9. PubMed ID: 8887453
[TBL] [Abstract][Full Text] [Related]
2. Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicol Appl Pharmacol; 1996 Dec; 141(2):555-60. PubMed ID: 8975781
[TBL] [Abstract][Full Text] [Related]
3. Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicology; 1999 Jun; 134(2-3):169-78. PubMed ID: 10403635
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.
Galli A; Mori F
Arch Toxicol; 1991; 65(4):330-4. PubMed ID: 1953352
[TBL] [Abstract][Full Text] [Related]
5. Protection of mice against soman by pretreatment with eptastigmine and physostigmine.
Tuovinen K; Hänninen O
Toxicology; 1999 Dec; 139(3):233-41. PubMed ID: 10647923
[TBL] [Abstract][Full Text] [Related]
6. Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies.
Braida D; Sala M
CNS Drug Rev; 2001; 7(4):369-86. PubMed ID: 11830755
[TBL] [Abstract][Full Text] [Related]
7. Organophosphate-induced convulsions and prevention of neuropathological damages.
Tuovinen K
Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
[TBL] [Abstract][Full Text] [Related]
8. Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine.
Harris L; Stitcher D
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):64-9. PubMed ID: 6493352
[TBL] [Abstract][Full Text] [Related]
9. Involvement of nitric oxide in myotoxicity produced by diisopropylphosphorofluoridate (DFP)-induced muscle hyperactivity.
Gupta RC; Milatovic D; Dettbarn WD
Arch Toxicol; 2002 Dec; 76(12):715-26. PubMed ID: 12451448
[TBL] [Abstract][Full Text] [Related]
10. Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats.
Scremin OU; Scremin AM; Heuser D; Hudgell R; Romero E; Imbimbo BP
J Cereb Blood Flow Metab; 1993 Jul; 13(4):702-11. PubMed ID: 8314923
[TBL] [Abstract][Full Text] [Related]
11. Assessment of diisopropylfluorophosphate (DFP) toxicity and tolerance in rats.
Lim DK; Hoskins B; Ho IK
Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):399-418. PubMed ID: 6856947
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation of phosphotriesterase within murine erythrocytes.
Pei L; Omburo G; McGuinn WD; Petrikovics I; Dave K; Raushel FM; Wild JR; DeLoach JR; Way JL
Toxicol Appl Pharmacol; 1994 Feb; 124(2):296-301. PubMed ID: 8122276
[TBL] [Abstract][Full Text] [Related]
13. Increased diisopropylfluorophosphate-induced toxicity in mu-opioid receptor knockout mice.
Tien LT; Fan LW; Ma T; Loh HH; Ho IK
J Neurosci Res; 2004 Oct; 78(2):259-67. PubMed ID: 15378609
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.
Deshpande SS; Viana GB; Kauffman FC; Rickett DL; Albuquerque EX
Fundam Appl Toxicol; 1986 Apr; 6(3):566-77. PubMed ID: 3699340
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes.
Petrikovics I; Hong K; Omburo G; Hu QZ; Pei L; McGuinn WD; Sylvester D; Tamulinas C; Papahadjopoulos D; Jaszberenyi JC; Way JL
Toxicol Appl Pharmacol; 1999 Apr; 156(1):56-63. PubMed ID: 10101099
[TBL] [Abstract][Full Text] [Related]
16. Physostigmine reverses cognitive dysfunction caused by moderate hypoxia in adult mice.
Bekker A; Haile M; Gingrich K; Wenning L; Gorny A; Quartermain D; Blanck T
Anesth Analg; 2007 Sep; 105(3):739-43. PubMed ID: 17717233
[TBL] [Abstract][Full Text] [Related]
17. [Experimental studies on the efficacy of PAM against sumithion poisoning].
Sekita K
Nihon Hoigaku Zasshi; 1992 Feb; 46(1):14-31. PubMed ID: 1597930
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological estimation of the actions of acetylcholinesterase inhibitors on acetylcholine receptor and cholinesterase in physically isolated Aplysia neurones.
Oyama Y; Hori N; Evans ML; Allen CN; Carpenter DO
Br J Pharmacol; 1989 Mar; 96(3):573-82. PubMed ID: 2720293
[TBL] [Abstract][Full Text] [Related]
19. Protection of organophosphate-inactivated esterases with phosphotriesterase.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Fundam Appl Toxicol; 1996 Jun; 31(2):210-7. PubMed ID: 8789787
[TBL] [Abstract][Full Text] [Related]
20. Protection against diisopropylfluorophosphate intoxication by meptazinol.
Galli A; Mazri A
Toxicol Appl Pharmacol; 1988 Sep; 95(3):388-96. PubMed ID: 3188007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]